Inventiva S.A. (IVA.PA)

EUR 2.95

(3.87%)

Total Liabilities Summary of Inventiva S.A.

  • Inventiva S.A.'s latest annual total liabilities in 2023 was 101.59 Million EUR , up 44.05% from previous year.
  • Inventiva S.A.'s latest quarterly total liabilities in 2023 FY was 101.59 Million EUR , up 44.05% from previous quarter.
  • Inventiva S.A. reported annual total liabilities of 70.52 Million EUR in 2022, up 112.96% from previous year.
  • Inventiva S.A. reported annual total liabilities of 33.11 Million EUR in 2021, up 19.53% from previous year.
  • Inventiva S.A. reported quarterly total liabilities of 101.59 Million EUR for 2023 FY, up 44.05% from previous quarter.
  • Inventiva S.A. reported quarterly total liabilities of 78.48 Million EUR for 2023 Q2, down 0.0% from previous quarter.

Annual Total Liabilities Chart of Inventiva S.A. (2023 - 2013)

Historical Annual Total Liabilities of Inventiva S.A. (2023 - 2013)

Year Total Liabilities Total Liabilities Growth
2023 101.59 Million EUR 44.05%
2022 70.52 Million EUR 112.96%
2021 33.11 Million EUR 19.53%
2020 27.7 Million EUR 77.98%
2019 15.56 Million EUR -14.54%
2018 18.21 Million EUR 75.86%
2017 10.35 Million EUR -21.15%
2016 13.13 Million EUR -26.22%
2015 17.8 Million EUR -17.67%
2014 21.62 Million EUR -23.05%
2013 28.1 Million EUR 0.0%

Peer Total Liabilities Comparison of Inventiva S.A.

Name Total Liabilities Total Liabilities Difference
ABIONYX Pharma SA 6.91 Million EUR -1369.806%
ABIVAX Société Anonyme 131.05 Million EUR 22.479%
Adocia SA 31.87 Million EUR -218.773%
Aelis Farma SA 13.08 Million EUR -676.705%
Biophytis S.A. 15.84 Million EUR -541.006%
Advicenne S.A. 24.37 Million EUR -316.758%
genOway Société anonyme 14.45 Million EUR -602.603%
IntegraGen SA 5.97 Million EUR -1598.937%
Medesis Pharma S.A. 6.42 Million EUR -1480.923%
Neovacs S.A. 3.71 Million EUR -2636.789%
NFL Biosciences SA 3.62 Million EUR -2705.907%
Plant Advanced Technologies SA 6.78 Million EUR -1397.902%
Quantum Genomics Société Anonyme 3.31 Million EUR -2969.176%
Sensorion SA 13.22 Million EUR -668.057%
Theranexus Société Anonyme 5.01 Million EUR -1925.302%
TME Pharma N.V. 2.78 Million EUR -3547.864%
Valbiotis SA 13.7 Million EUR -641.122%
TheraVet SA 1.48 Million EUR -6741.312%
Valerio Therapeutics Société anonyme 20.46 Million EUR -396.35%
DBV Technologies S.A. 38.74 Million USD -162.207%
Genfit S.A. 105.92 Million EUR 4.086%
GeNeuro SA 20.13 Million EUR -404.436%
Innate Pharma S.A. 132.29 Million EUR 23.205%
MaaT Pharma SA 22.46 Million EUR -352.228%
MedinCell S.A. 77.77 Million EUR -30.633%
Nanobiotix S.A. 95.74 Million EUR -6.113%
OSE Immunotherapeutics SA 59.07 Million EUR -71.961%
Poxel S.A. 53.9 Million EUR -88.481%
GenSight Biologics S.A. 34.72 Million EUR -192.548%
Transgene SA 26.51 Million EUR -283.124%
Valneva SE 341.14 Million EUR 70.22%